Asher Nathan

Asher Nathan is the co-founder and CEO of NeoTX Therapeutics LTD, an Israeli biopharmaceutical company focused on oncology research and development.1

Background and Education

Nathan is originally from Chicago but moved to Israel many years ago. He received his BSc in chemistry and biology from the University of Illinois and continued his studies at The Hebrew University of Jerusalem.1

Career Highlights

• Biotechnology Experience: Nathan has an extensive background in biotechnology, with expertise in business strategy, development, and entrepreneurship.1
• Previous Roles:
  • Managing Director at Paramount Biocapital
  • Founder of IntelliGenne and EvoRx
  • Managing Partner and co-founder of Zoticon Bioventures1
• Innovations: He has authored over 25 patents in the biotechnology field.1

NeoTX Therapeutics

Nathan co-founded NeoTX in 2015 and has since served as its CEO.12 The company has developed a Tumor Targeted Superantigen (TTS) platform technology, which aims to enhance the body's immune response against cancer cells.1

Leadership Philosophy

Nathan's approach to running NeoTX is based on two main strategies:

1. Think differently: He believes in taking a unique approach to overcome the challenges of killing cancer cells.1
2. Think big: Nathan aims to integrate drug discovery with breakthrough technology and drug development to create a leading company for oncology treatment.1

Personal Perspective

Nathan is particularly drawn to oncology, describing it as a challenging field that he compares to "the lure of a casino." He is driven by the complex task of developing drugs that can effectively target cancer cells without harming healthy ones.12